These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27580960)

  • 1. SOX10 expression in cutaneous scars: a potential diagnostic pitfall in the evaluation of melanoma re-excision specimens.
    Jackett LA; McCarthy SW; Scolyer RA
    Pathology; 2016 Oct; 48(6):626-8. PubMed ID: 27580960
    [No Abstract]   [Full Text] [Related]  

  • 2. Sox10-Positive Cells Within Scars: A Potential Diagnostic Pitfall.
    Harvey NT; Acott NJ; Wood BA
    Am J Dermatopathol; 2017 Oct; 39(10):791-793. PubMed ID: 27759704
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid SOX10 Immunostain on Fresh Frozen Tissue.
    Donaldson MR; Deeths MJ; Weber LA
    Dermatol Surg; 2016 Feb; 42(2):269-71. PubMed ID: 26808180
    [No Abstract]   [Full Text] [Related]  

  • 4. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
    Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
    J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin.
    Lezcano C; Ho J; Seethala RR
    Am J Dermatopathol; 2017 Dec; 39(12):896-902. PubMed ID: 28394798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX10 commonly stains scar in Mohs sections.
    Donaldson MR; Weber LA
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma.
    Robson A; Allen P; Hollowood K
    Histopathology; 2001 Feb; 38(2):135-40. PubMed ID: 11207826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin.
    Muzumdar S; Argraves M; Kristjansson A; Ferenczi K; Dadras SS
    J Cutan Pathol; 2018 Apr; 45(4):263-268. PubMed ID: 29377259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
    Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
    Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.
    Otaibi S; Jukic DM; Drogowski L; Bhawan J; Radfar A
    Am J Dermatopathol; 2011 Feb; 33(1):65-71. PubMed ID: 21178583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX-10 staining in dermal scars.
    Behrens EL; Boothe W; D'Silva N; Walterscheid B; Watkins P; Tarbox M
    J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
    Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
    Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal Expression of SRY-related HMG-BOX Gene 10 (SOX-10) in Recent and Old Cutaneous Scars is a Potential Mimicker of Desmoplastic Malignant Melanoma.
    Febres-Aldana CA; Alexis J
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):197-204. PubMed ID: 30672775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic triple-negative breast carcinoma mimicking melanoma: A potential diagnostic pitfall.
    Fliorent R; Benedetto C; Theroux Z
    J Cutan Pathol; 2024 Sep; 51(9):654-657. PubMed ID: 38767140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
    Blokzijl A; Chen LE; Gustafsdottir SM; Vuu J; Ullenhag G; Kämpe O; Landegren U; Kamali-Moghaddam M; Hedstrand H
    PLoS One; 2016; 11(4):e0154214. PubMed ID: 27110718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
    Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity for Sox10 in Basaloid Neoplasms of The Skin.
    Bush JW; Gru AA; Wick MR
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):114-118. PubMed ID: 30531326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma.
    Chorny JA; Barr RJ
    Am J Dermatopathol; 2002 Aug; 24(4):309-12. PubMed ID: 12142609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
    Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
    Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining diagnosis is the prerequisite for the correct treatment: The cytodiagnostic utility of SOX10 in the diagnosis of metastatic melanoma.
    Kilitçi A; Elmas ÖF; Demirbaş A; Gamsızkan M; Atasoy M; Türsen Ü; Lotti T
    Dermatol Ther; 2021 Jan; 34(1):e14657. PubMed ID: 33301211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.